FDA and uniQure Align on Accelerated Approval Pathway for AMT-130 in Huntington Disease Rare Disease Advisor 16:59 Fri, 19 Jun
Huntington's Disease Gene Therapy AMT-130 Is on Track for FDA Approval After uniQure Reaches Regulatory Agreement Medical Daily 13:00 Fri, 19 Jun
Why uniQure (QURE) Is Up 72.9% After FDA Backs AMT-130 Data For Accelerated Approval Prospects Simply Wall St 03:55 Fri, 19 Jun
UniQure to seek approval of Huntington’s gene therapy after FDA U-turn Pharmaceutical Technology 18:19 Thu, 18 Jun
Flexibility restored? Uniqure plans for Bla filing in Huntington’s BioWorld 21:52 Wed, 17 Jun Article paywall
FDA Pendulum Swing Means A Green Light For UniQure AMT-130 Scrip Pharma Intelligence 19:41 Wed, 17 Jun
UniQure to file gene therapy for approval, reflecting major shifts at FDA BioPharma Dive 18:51 Wed, 17 Jun
uniQure Stock Surges 76% on FDA Breakthrough for Huntington's Gene Therapy Amt-130 International Business Times - AU Edition 16:41 Wed, 17 Jun
UniQure Moves Toward Accelerated Approval Path For Amt-130 After FDA Signals Support; Stock Up RTT News 16:20 Wed, 17 Jun
Jabil Posts Upbeat Q3 Results, Joins Uniqure, Braiin And Other Big Stocks Moving Higher On Wednesday Benzinga 15:15 Wed, 17 Jun Article paywall
STAT Plus: Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approval STAT 12:54 Wed, 17 Jun
A Look At uniQure (QURE) Valuation After Strong Recent Share Price Gains Simply Wall St 02:17 Tue, 02 Jun
A Look At uniQure (QURE) Valuation After AMT-130 Gene Therapy Regulatory Plans And Trial Update Simply Wall St 13:28 Mon, 25 May
